FFCP PHASE1:Hg19::chr20:15966870..15966891,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=NA | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript | |||
|HGNC=NA | |||
|TSSclassifier=not | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|coexpression_cluster_id=C1862 | |||
|description=CAGE_peak_at_chr20:15966870..15966891,+ | |||
|id=chr20:15966870..15966891,+ | |||
|ontology_enrichment_celltype=CL:0000945!4.10e-34!24;CL:0000826!4.10e-34!24;CL:0000236!3.39e-29!14;CL:0000838!1.71e-19!52;CL:0000542!4.59e-19!53;CL:0000051!4.59e-19!53;CL:0000313!6.23e-07!1 | |||
|ontology_enrichment_celltype_v019=CL:0000313;1.30e-19;1!CL:0000236;5.16e-13;13!CL:0000159;1.72e-10;2!CL:0000542;9.31e-09;53!CL:0000945;2.54e-07;24 | |||
|ontology_enrichment_celltype_v019_2=CL:0000313,1.30e-19,1;CL:0000236,4.50e-12,14;CL:0000159,1.72e-10,2;CL:0000838,1.08e-08,52;CL:0000542,1.57e-08,53;CL:0000051,1.57e-08,53;CL:0000945,2.74e-07,24;CL:0000826,2.74e-07,24 | |||
|ontology_enrichment_development_v019=CL:0000051;9.31e-09;53 | |||
|ontology_enrichment_disease=DOID:299!1.81e-12!25;DOID:4468!4.16e-12!2;DOID:2152!6.23e-07!1 | |||
|ontology_enrichment_disease_v019=DOID:4468;4.32e-37;2!DOID:2152;1.30e-19;1!DOID:299;5.46e-12;25!DOID:3493;2.07e-10;2 | |||
|ontology_enrichment_disease_v019_2=DOID:4468,4.73e-37,2;DOID:2152,1.30e-19,1;DOID:299,5.54e-12,25;DOID:3493,2.07e-10,2 | |||
|ontology_enrichment_uberon=UBERON:0002106!8.48e-08!3;UBERON:0004854!8.48e-08!3;UBERON:0009034!8.48e-08!3;UBERON:0002095!8.48e-08!3;UBERON:0004782!8.48e-08!3;UBERON:0003281!8.48e-08!3;UBERON:0009664!8.48e-08!3;UBERON:0002296!8.48e-08!3;UBERON:0005602!8.48e-08!3;UBERON:0001179!8.48e-08!3;UBERON:0006293!8.48e-08!3;UBERON:0006562!2.95e-07!11;UBERON:0004177!5.34e-07!7;UBERON:0004911!6.23e-07!1 | |||
|ontology_enrichment_uberon_v019=UBERON:0004911;1.30e-19;1!UBERON:0004909;1.72e-10;2 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0004911,1.30e-19,1;UBERON:0004909,1.72e-10,2 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.305653622991805,0.410502947249729,0.708397031823113,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.77901850772711,0.853460445133014,1.60158394814405,0.574752439954483,0.661044872784862,0.954053754535364,1.1384259382189,0.587237189370939,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.141775097242386,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.238231775457789,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.37428108081644,0,0,0,0,0,0,0,0,0,0,3.79048910721547,0,0,0.276283915531148,0,0,0,0,0.179736702294654,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.68798451622422,43.5831597784924,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.284609546029793,0,0.694238953340524,0.0979923974143777,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.8402114799552,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.121792598380896,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,40.2299184183076,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.127762427639595,0,0,0,0,0,0.345701962667338,0,0,0,0,0,0,0,0,0,1.94334832096759,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,37.2478587886648,0,2.31644057466312,0.647428837187895,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.281951753939561,0,0.599646935549574,0,0,0,0,0,0,0,0,0,0.5290268405154,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0645889098360061,0,0,0,0,0.217716747896961,0,0.0673520530145875,0,0,0.162806537221949,0,0,0.449126010532934,0,0,0,0,0,0 | |||
|short_description=p@chr20:15966870..15966891,+ | |||
}} |
Revision as of 10:20, 21 January 2014
Short description: | p@chr20:15966870..15966891, + |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | No |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chr20:15966870..15966891, + |
Coexpression cluster: | C1862_mesothelioma_serous_clear_kidney_heart_hepatoma_cervical |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
serous secreting cell | 1.30e-19 | 1 |
B cell | 4.50e-12 | 14 |
seromucus secreting cell | 1.72e-10 | 2 |
lymphoid lineage restricted progenitor cell | 1.08e-08 | 52 |
lymphocyte | 1.57e-08 | 53 |
common lymphoid progenitor | 1.57e-08 | 53 |
lymphocyte of B lineage | 2.74e-07 | 24 |
pro-B cell | 2.74e-07 | 24 |
Ontology term | p-value | n |
---|---|---|
epithelium of female gonad | 1.30e-19 | 1 |
epithelium of gonad | 1.72e-10 | 2 |
Ontology term | p-value | n |
---|---|---|
clear cell adenocarcinoma | 4.73e-37 | 2 |
ovary epithelial cancer | 1.30e-19 | 1 |
adenocarcinoma | 5.54e-12 | 25 |
signet ring cell adenocarcinoma | 2.07e-10 | 2 |